
Studying T-Cell Therapy for Potential Lung Tissue Repair with Benjamin Singer, MD
About this episode
Viral pneumonia can cause severe lung damage and make recovery long and life-threatening for patients. Current treatments only provide support, not repair, but Northwestern Medicine scientist Benjamin Singer, MD, wants to change that.
In this episode, he details a recent discovery from his team that found laboratory-modified T-cells or induced regulatory T-cells (iTregs), can promote lung tissue repair in mice with severe influenza pneumonia. Singer discusses this breakthrough and how it could lead to an effective cellular therapy for patients with severe viral pneumonia and acute respiratory distress syndrome in the future.
Get every episode summarized
Each time Breakthroughs publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Breakthroughs

Improving Testing and Diagnosis of Hepatitis C with Claudia Hawkins, MD, MPH
Breakthroughs

Decoding Long COVID's Impact on the Brain with Igor Koralnik, MD
Breakthroughs

Improving Imaging of the Spinal Cord with Molly Bright, DPhil
Breakthroughs

New Paths for Diagnosing and Treating Lyme Disease with Brandon Jutras, PhD
Breakthroughs